Analysis of IFN-κ expression in pathologic skin conditions: Downregulation in psoriasis and atopic dermatitis

Claudia Scarponi, Bernardetta Nardelli, David W. Lafleur, Paul A. Moore, Stefania Madonna, Ornella De Pità, Giampiero Girolomoni, Cristina Albanesi

Research output: Contribution to journalArticle

Abstract

Interferon-κ (IFN-κ) is a type I IFN expressed by keratinocytes, monocytes and dendritic cells (DCs). In human keratinocytes, it is produced in response to double-stranded RNA (dsRNA) and other IFNs and protects from viral infections. In monocytes and DCs, IFN-κ induces tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) and inhibits lipopolysaccharide (LPS)-induced IL-12. In this study, we evaluated IFN-κ expression in skin lesions of patients with common immune-mediated inflammatory disorders using immunohistochemical techniques. IFN-κ was not detectable in healthy skin but was strongly expressed in allergic contact dermatitis and lichen planus-affected skin. IFN-κ was localized mainly in basal and suprabasal keratinocytes and in some leukocytes infiltrating the dermis. In contrast, IFN-κ expression in psoriatic or atopic dermatitis (AD) epidermis was weak and detectable in only 2 of 5 patients examined. Consistently, cultured keratinocytes and monocytes obtained from psoriatic and AD patients expressed null or low levels of IFN-κ in response to IFN-γ, which strongly upregulates IFN-κ in normal keratinocytes. IFN-κ accumulated in keratinocyte cytoplasm and plasma membrane, and only limited amounts were released extracellularly. Soluble IFN-κ did not influence keratinocyte proliferation or chemokine and membrane molecule expression, and only its membrane-associated form activated IFN-stimulated response element (ISRE) signaling. Given the difference in IFN-κ expression levels in the skin disorders examined, IFN-κ presence or deficiency might have different pathogenetic consequences depending also on other disease-specific intrinsic alterations.

Original languageEnglish
Pages (from-to)133-140
Number of pages8
JournalJournal of Interferon and Cytokine Research
Volume26
Issue number3
DOIs
Publication statusPublished - Mar 2006

Fingerprint

Atopic Dermatitis
Psoriasis
Interferons
Down-Regulation
Skin
Keratinocytes
Monocytes
Dendritic Cells
Lichen Planus
Allergic Contact Dermatitis
Membranes
Double-Stranded RNA
Response Elements
Virus Diseases
Interleukin-12
Dermis
Chemokines
Epidermis
Interleukin-10
Lipopolysaccharides

ASJC Scopus subject areas

  • Immunology
  • Virology
  • Cell Biology

Cite this

Analysis of IFN-κ expression in pathologic skin conditions : Downregulation in psoriasis and atopic dermatitis. / Scarponi, Claudia; Nardelli, Bernardetta; Lafleur, David W.; Moore, Paul A.; Madonna, Stefania; De Pità, Ornella; Girolomoni, Giampiero; Albanesi, Cristina.

In: Journal of Interferon and Cytokine Research, Vol. 26, No. 3, 03.2006, p. 133-140.

Research output: Contribution to journalArticle

Scarponi, Claudia ; Nardelli, Bernardetta ; Lafleur, David W. ; Moore, Paul A. ; Madonna, Stefania ; De Pità, Ornella ; Girolomoni, Giampiero ; Albanesi, Cristina. / Analysis of IFN-κ expression in pathologic skin conditions : Downregulation in psoriasis and atopic dermatitis. In: Journal of Interferon and Cytokine Research. 2006 ; Vol. 26, No. 3. pp. 133-140.
@article{3e22a2213ba04c31ae92c385f9b26b60,
title = "Analysis of IFN-κ expression in pathologic skin conditions: Downregulation in psoriasis and atopic dermatitis",
abstract = "Interferon-κ (IFN-κ) is a type I IFN expressed by keratinocytes, monocytes and dendritic cells (DCs). In human keratinocytes, it is produced in response to double-stranded RNA (dsRNA) and other IFNs and protects from viral infections. In monocytes and DCs, IFN-κ induces tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) and inhibits lipopolysaccharide (LPS)-induced IL-12. In this study, we evaluated IFN-κ expression in skin lesions of patients with common immune-mediated inflammatory disorders using immunohistochemical techniques. IFN-κ was not detectable in healthy skin but was strongly expressed in allergic contact dermatitis and lichen planus-affected skin. IFN-κ was localized mainly in basal and suprabasal keratinocytes and in some leukocytes infiltrating the dermis. In contrast, IFN-κ expression in psoriatic or atopic dermatitis (AD) epidermis was weak and detectable in only 2 of 5 patients examined. Consistently, cultured keratinocytes and monocytes obtained from psoriatic and AD patients expressed null or low levels of IFN-κ in response to IFN-γ, which strongly upregulates IFN-κ in normal keratinocytes. IFN-κ accumulated in keratinocyte cytoplasm and plasma membrane, and only limited amounts were released extracellularly. Soluble IFN-κ did not influence keratinocyte proliferation or chemokine and membrane molecule expression, and only its membrane-associated form activated IFN-stimulated response element (ISRE) signaling. Given the difference in IFN-κ expression levels in the skin disorders examined, IFN-κ presence or deficiency might have different pathogenetic consequences depending also on other disease-specific intrinsic alterations.",
author = "Claudia Scarponi and Bernardetta Nardelli and Lafleur, {David W.} and Moore, {Paul A.} and Stefania Madonna and {De Pit{\`a}}, Ornella and Giampiero Girolomoni and Cristina Albanesi",
year = "2006",
month = "3",
doi = "10.1089/jir.2006.26.133",
language = "English",
volume = "26",
pages = "133--140",
journal = "Journal of Interferon and Cytokine Research",
issn = "1079-9907",
publisher = "Mary Ann Liebert Inc.",
number = "3",

}

TY - JOUR

T1 - Analysis of IFN-κ expression in pathologic skin conditions

T2 - Downregulation in psoriasis and atopic dermatitis

AU - Scarponi, Claudia

AU - Nardelli, Bernardetta

AU - Lafleur, David W.

AU - Moore, Paul A.

AU - Madonna, Stefania

AU - De Pità, Ornella

AU - Girolomoni, Giampiero

AU - Albanesi, Cristina

PY - 2006/3

Y1 - 2006/3

N2 - Interferon-κ (IFN-κ) is a type I IFN expressed by keratinocytes, monocytes and dendritic cells (DCs). In human keratinocytes, it is produced in response to double-stranded RNA (dsRNA) and other IFNs and protects from viral infections. In monocytes and DCs, IFN-κ induces tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) and inhibits lipopolysaccharide (LPS)-induced IL-12. In this study, we evaluated IFN-κ expression in skin lesions of patients with common immune-mediated inflammatory disorders using immunohistochemical techniques. IFN-κ was not detectable in healthy skin but was strongly expressed in allergic contact dermatitis and lichen planus-affected skin. IFN-κ was localized mainly in basal and suprabasal keratinocytes and in some leukocytes infiltrating the dermis. In contrast, IFN-κ expression in psoriatic or atopic dermatitis (AD) epidermis was weak and detectable in only 2 of 5 patients examined. Consistently, cultured keratinocytes and monocytes obtained from psoriatic and AD patients expressed null or low levels of IFN-κ in response to IFN-γ, which strongly upregulates IFN-κ in normal keratinocytes. IFN-κ accumulated in keratinocyte cytoplasm and plasma membrane, and only limited amounts were released extracellularly. Soluble IFN-κ did not influence keratinocyte proliferation or chemokine and membrane molecule expression, and only its membrane-associated form activated IFN-stimulated response element (ISRE) signaling. Given the difference in IFN-κ expression levels in the skin disorders examined, IFN-κ presence or deficiency might have different pathogenetic consequences depending also on other disease-specific intrinsic alterations.

AB - Interferon-κ (IFN-κ) is a type I IFN expressed by keratinocytes, monocytes and dendritic cells (DCs). In human keratinocytes, it is produced in response to double-stranded RNA (dsRNA) and other IFNs and protects from viral infections. In monocytes and DCs, IFN-κ induces tumor necrosis factor-α (TNF-α) and interleukin-10 (IL-10) and inhibits lipopolysaccharide (LPS)-induced IL-12. In this study, we evaluated IFN-κ expression in skin lesions of patients with common immune-mediated inflammatory disorders using immunohistochemical techniques. IFN-κ was not detectable in healthy skin but was strongly expressed in allergic contact dermatitis and lichen planus-affected skin. IFN-κ was localized mainly in basal and suprabasal keratinocytes and in some leukocytes infiltrating the dermis. In contrast, IFN-κ expression in psoriatic or atopic dermatitis (AD) epidermis was weak and detectable in only 2 of 5 patients examined. Consistently, cultured keratinocytes and monocytes obtained from psoriatic and AD patients expressed null or low levels of IFN-κ in response to IFN-γ, which strongly upregulates IFN-κ in normal keratinocytes. IFN-κ accumulated in keratinocyte cytoplasm and plasma membrane, and only limited amounts were released extracellularly. Soluble IFN-κ did not influence keratinocyte proliferation or chemokine and membrane molecule expression, and only its membrane-associated form activated IFN-stimulated response element (ISRE) signaling. Given the difference in IFN-κ expression levels in the skin disorders examined, IFN-κ presence or deficiency might have different pathogenetic consequences depending also on other disease-specific intrinsic alterations.

UR - http://www.scopus.com/inward/record.url?scp=33645387727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645387727&partnerID=8YFLogxK

U2 - 10.1089/jir.2006.26.133

DO - 10.1089/jir.2006.26.133

M3 - Article

C2 - 16542135

AN - SCOPUS:33645387727

VL - 26

SP - 133

EP - 140

JO - Journal of Interferon and Cytokine Research

JF - Journal of Interferon and Cytokine Research

SN - 1079-9907

IS - 3

ER -